Synthesis of selenocysteine peptides and their oxidation to diselenide-bridged compounds.
Using the Fmoc/tBu protection scheme and the p-methoxybenzyl derivative of selenocysteine, the synthesis of related peptides in the selenol-protected form could be optimized by operating the coupling steps in the absence of auxiliary bases and by reducing the piperidine treatment to the minimum time required for quantitative Fmoc cleavage. Under these conditions, beta-elimination of the p-methoxybenzylselenol as the main side reaction of these syntheses, as well as epimerization of the protected selenocysteine, was largely suppressed. Conversion of the selenol- and thiol-protected bis-selenocysteine and selenocysteine, cysteine peptides into the related cyclic monomeric forms by iodine-mediated oxidation failed since a complex mixture of compounds was produced. Cleavage of the selenoether bond with mercuric acetate was found to proceed smoothly, but displacement of the heavy metal ions by treatment with excesses of thiols or hydrogen sulphide was unsuccessful since a stable Hg2+ diselenide complex was obtained. However, oxidation was achieved in good yields by the dimethylsulphoxide/trifluoroacetic acid procedure and the peptides were then used for determining the redox potential of the diselenide and selenide/sulphide bridge, respectively.
Besse
D
D
Max-Planck-Institute of Biochemistry, Martinsried, Germany.
Moroder
L
L
D016566:Organoselenium Compounds / Q000138:chemical synthesis* / Q000378:metabolism; D010084:Oxidation-Reduction; D010455:Peptides / Q000138:chemical synthesis* / Q000378:metabolism; D011487:Protein Conformation; D017279:Selenocysteine / Q000737:chemistry* / Q000378:metabolism
D016566:Organoselenium Compounds; D010455:Peptides; D017279:Selenocysteine